Lysophosphatidic Acid Promoting Corneal Epithelial Wound Healing by Transactivation of Epidermal Growth Factor Receptor
Open Access
- 1 February 2007
- journal article
- cornea
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 48 (2) , 636-643
- https://doi.org/10.1167/iovs.06-0203
Abstract
Purpose. To identify the underlying mechanisms by which lipid mediator lysophosphatidic acid (LPA) acts as a growth factor in stimulating extracellular signal–regulated kinase (ERK) and phosphatidylinositol 3′-kinase (PI3K) during corneal epithelial wound healing. methods. Epithelial debridement wounds in cultured porcine corneas and scratch wounds in an epithelial monolayer of SV40-immortalized human corneal epithelial (THCE) cells were allowed to heal in the presence or absence of an epidermal growth factor receptor (EGFR) inhibitor (tyrphostin AG1478), a matrix metalloproteinase inhibitor (GM6001), or a heparin-binding EGF-like growth factor (HB-EGF) antagonist (CRM197) with or without LPA. EGFR activation was analyzed by immunoprecipitation using EGFR antibodies and Western blotting with phosphotyrosine antibodies. Phosphorylation of ERK and AKT (a major substrate of PI3K) was analyzed by Western blotting with antibodies specific to the phosphorylated proteins. Wound- and LPA-induced shedding of HB-EGF was assessed by measuring the release of alkaline phosphatase (AP) in a stable THCE cell line that expressed HB-EGF with AP inserted in the heparin-binding site. results. In organ and cell culture models, LPA enhanced corneal epithelial wound healing. LPA-stimulated and spontaneous wound closure was attenuated by AG1478, GM6001, or CRM197. Consistent with the effects on epithelial migration, these inhibitors, as well as the Src kinase inhibitor (PP2), retarded LPA-induced activation of EGFR and its downstream effectors ERK and AKT in THCE cells. Unlike exogenously added HB-EGF, LPA stimulated moderate EGFR phosphorylation; the level of phosphorylated EGFR was similar to that induced by wounding. However, LPA appeared to prolong wound-induced EGFR signaling. The release of HB-EGF assessed by AP activity increased significantly in response to wounding, LPA, or both, and the release of HB-EGF-AP induced by LPA was inhibited by PP2 and GM6001. conclusions. LPA accelerates corneal epithelial wound healing through its ability to induce autocrine HB-EGF signaling. Transactivation of EGFR by LPA represents a convergent signaling pathway accessible to stimuli such as growth factors and ligands of G-protein–coupled receptors in response to pathophysiological challenge in human corneal epithelial cells.Keywords
This publication has 61 references indexed in Scilit:
- Src-Family Tyrosine Kinases in Wound- and Ligand-Induced Epidermal Growth Factor Receptor Activation in Human Corneal Epithelial CellsInvestigative Opthalmology & Visual Science, 2006
- The ins and outs of lysophosphatidic acid signalingBioEssays, 2004
- Lysophosphatidic acid: mitogen and motility factorBiochemical Society Transactions, 2003
- Enhancement of Lysophosphatidic Acid-Induced ERK Phosphorylation by Phospholipase D1 via the Formation of Phosphatidic AcidBiochemical and Biophysical Research Communications, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in InflammationScience, 2000
- A Simple Organ Culture Model for Assessing the Effects of Growth Factors on Corneal Re-epithelializationExperimental Eye Research, 1996
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Growth factor-like effects of lysophosphatidic acid, a novel lipid mediatorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Biosynthesis and Processing by Phorbol Ester of the Cell Surface-Associated Precursor Form of Heparin-Binding EGF-like Growth FactorBiochemical and Biophysical Research Communications, 1994